- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide (Revlimid)
Total 1146 results
-
Nanjing University School of MedicineEnrolling by invitationAL Amyloidosis | Plasma Cell DyscrasiaChina
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
TakedaActive, not recruiting
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
Aalborg University HospitalAalborg UniversityActive, not recruitingChemotherapy-induced Peripheral NeuropathyDenmark
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
CelgeneTerminatedLymphoma, Large B-Cell, DiffuseUnited States, France, Canada, Italy
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
Hoffmann-La RocheCompletedRelapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, Spain, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
Bristol-Myers SquibbAbbVieNo longer available
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Henan Cancer HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Bristol-Myers SquibbNo longer available
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
iOMEDICO AGCompleted
-
Canadian Myeloma Research GroupActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedMantle Cell Lymphoma | UntreatedUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
Nurix Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Primary Central Nervous System Lymphoma (PCNSL) | Marginal Zone Lymphoma (MZL) | Waldenstrom Macroglobulinemia (WM)United States
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingSmouldering MyelomaNetherlands, Norway, Czechia, Italy
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Celgene Corporation; University... and other collaboratorsCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
New Approaches to Neuroblastoma Therapy ConsortiumNationwide Children's Hospital; United TherapeuticsActive, not recruitingNeuroblastomaUnited States
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
CelgeneCompletedMultiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
iOMEDICO AGActive, not recruitingMultiple Myeloma | Patient Satisfaction | Personal Satisfaction | Newly Diagnosed | Transplant Ineligible | Patient PreferenceGermany
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Nantes University HospitalCompleted
-
Janssen Research & Development, LLCCompleted
-
KRL Hospital, IslamabadCompletedTraumatic Brain InjuryPakistan
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDiarrhea | Multiple MyelomaUnited States
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Newly Diagnosed PatientsItaly
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Fondazione EMN Italy OnlusCompleted